The decision of how to allocate subjects to treatment groups is of great importance in experimental clinical trials for novel investigational drugs, a multi-billion dollar industry. Statistical power, the ability of an experiment to detect a positive treatment effect when one exists, depends in part on the similarity of the groups in terms of measurable covariates that affect the treatment response. We present a novel algorithm for online allocation that leverages robust mixed-integer optimization. In all tested scenarios, the proposed method yields statistical power at least as high as, and sometimes significantly higher than, state-of-the-art covariate-adaptive randomization approaches. We present a setting in which our algorithm achieves a desired level of power at a sample size 25-50% smaller than that required with randomization-based approaches. Correspondingly, we expect that our covariate-adaptive optimization approach could substantially reduce both the duration and operating costs of clinical trials in many commonly observed settings, while maintaining computational efficiency and protection against experimental bias.
Introduction
A central task in formal experimentation for scientific inquiry is to identify unique groups of subjects which should be administered alternate treatment conditions. In particular, the groups should be as similar as possible as defined by measurable covariates, or attributes, which affect
w i x ip and σ x ip = 1, ∀i = 1, . . . , N x ip = 0 ∀i < p.
The final constraint reduces the redundancy due to permutation symmetry in group numbering.
In all tested scenarios from Bertsimas et al. (2015) , the OPT method generates groups with covariate discrepancy that is exponentially lower in the group size k than those created by randomization. The expected average covariate discrepancy decreases from O(k −1/2 ) for randomization to O(2 −k ) for the OPT algorithm. Furthermore, the OPT algorithm demonstrates exceptional precision in estimating small treatment effects and superior statistical power given a fixed treatment effect.
For the remainder of this paper, the OPT algorithm will serve as a prescient benchmark for the performance of methods in the setting of sequential online allocation.
Covariate-Adaptive Optimization Algorithms
In this section, we introduce the CA-RO algorithm, develop an extension in which aggregation of decisions is allowed, and describe the results of empirical experiments comparing the covariate balance of CA-RO versus CA-RAND methods.
CA-RO Algorithm
To extend the model from Section 2 to the online setting, we consider the problem of N subjects arriving sequentially. The decision-maker knows a priori the number of subjects k that will be assigned to each of m ≥ 2 treatment groups, such that N = km. In practical settings with sequential arrivals, it is often reasonable to assume that investigators will have at least an estimate of the number of subjects that will enroll based on the timeline, budget constraints, and prevalence of disease in the population.
At each time-step t = 1, . . . , N , where t indexes both the period and the subject, the decisionmaker observes the covariate vector w t ∈ R S , where S is the number of covariates observed for each subject. We assume that this sequence of random covariate vectors is exchangeable, such that any ordering of the subjects' arrival is equally likely. The decision-maker then sets a decision {x tp } m p=1 ∈ {0, 1} m , where x tp = 1, if the decision-maker assigns subject t to group p ∈ {1, . . . , m}, and x tp = 0, otherwise. In the CA-RO algorithm, the choice of {x tp } m p=1 is made by solving one instance of robust MIO formulation (2) at each time-step. The data for the optimization at timestep t include the covariate observations {w i } t i=1 and assignmentsx := {x ip i = 1, . . . , t − 1, p = 1, . . . , m} ∈ {0, 1} (t−1)×m made at all previous time-steps. We define expressions for the sample meanw t and the empirical covariance matrix Σ t at time-step t as follows:
(w i −w t )(w i −w t ) .
We also define uncertain parametersw :
, which represent the unknown covariates for future subjects.
The objective of the CA-RO algorithm is to produce m groups whose covariate distributions are as similar as possible. We measure the proximity between two groups p and q in terms of the mean 
where x := {x ip ∈ {0, 1} i = t, . . . , N, p = 1, . . . , m} are the binary assignment decision variables.
We model the decision at each time-step t = 1, . . . , N by the following optimization problem:
Given that the values of future covariatesw are unknown, we employ robust optimization (Ben-Tal et al. 2002) to model formulation (1) under uncertainty:
In this formulation, we use the uncertainty set U w defined as follows:
where perturbation vector ε = (ε t+1 , . . . , ε N ) belongs to the ellipsoidal uncertainty set U ε :
The robustness parameter Γ controls the size of the ellipsoid and represents the level of conservatism of the uncertainty set. In order to protect against experimental biases, we suggest that Γ should be chosen independently at random for each time-step (see Section 5).
Formulation (2) takes the form of a mixed-binary quadratic robust optimization problem with conic uncertainty set, which cannot be solved using off-the-shelf commercial solvers. We overcome this computational challenge by finding an efficient way to solve the following auxiliary optimization problems with respect to the uncertain variablesw:
and max
The objectives of optimization problems (4) are to maximize a linear or quadratic function, respectively, over an ellipsoid. The unique structure of these problems allows us to derive closed-form solutions by applying Karush-Kuhn-Tucker conditions along with eigenvalue optimization. Therefore, formulation (2) is equivalent to a mixed-binary optimization problem, described in (EC .7) and (EC.8) in section EC.2 of the e-companion, that can be solved via simple enumeration of at most m scenarios.
Aggregated CA-RO algorithm
The development of a partially online method is motivated by the opportunity presented when multiple subjects enroll in a clinical trial within a short period of time. Under these circumstances, the decision-maker may be able to make a joint decision regarding the simultaneous assignment of this sub-cohort of subjects to treatment groups.
For this analysis, we will distinguish the notion of time from the arrival of subjects. Time will be indexed by periods t = 1, . . . , T . Subjects will be indexed separately by i = 1, . . . , N with covariate vectors w i ∈ R S , where N ≥ T . Both the number of periods T and the number of subjects N are known a priori. We assume that at time t the decision-maker has observed the covariate values for r t ≥ 1 unassigned subjects who have arrived during time period t. Let us define n t := t j=1 r j to represent the number of subjects who have arrived as of time t. We also introduce the vector
. We can then define the following expressions to represent the sample mean and approximated variance of group p with respect to covariate s at time t: 
In the aggregated CA-RO algorithm, we solve formulation (2) at each time-step t, but we replace the expressions µ s p and σ s p with their generalized counterparts µ s p (r t ) and σ s p (r t ), respectively. The optimal solutions {x * ip ∈ {0, 1} | i = n t − r t + 1, . . . , n t , p = 1, . . . , m} to the corresponding MIO problem are used to make the assignments at period t for r t subjects. The problem can be solved at time t by enumeration with complexity O(m r t ), and is therefore computationally tractable for instances of practical size.
If the aggregation level is uniform across time such that r t = r for all t = 1, . . . , T − 1 and r T = N − (T − 1)r, we define the CA-RO(r) algorithm with aggregation level r. We observe that the CA-RO(1) algorithm is equivalent to the fully online CA-RO algorithm and the CA-RO(N ) algorithm is equivalent to the OPT algorithm from Section 2.
It is reasonable to assume that larger values of the aggregation parameter r lead to better performance of the partially online algorithm in terms of both covariate balance and statistical power. With a higher level of aggregation, the decision-maker has more information at the time of each decision. In Section 3.4, we provide empirical evidence for this relationship.
Practical Considerations
When using the CA-RO algorithm in practice, we suggest a few modifications and parameter selection guidelines.
1. At the beginning of the assignment process, group indices p = 1, . . . , m can be randomly assigned to each of the treatment conditions. In this way, the CA-RO algorithm is used to identify groups that are well-balanced with respect to observed covariates, but plays no role in determining which group should receive which treatment.
2. In the objective of formulation (2), the parameter ρ controls the tradeoff between imbalance in the sample mean and the approximated variance. In practice, to facilitate an intuitive choice of ρ, it is convenient to substitute the objective max follow, we use this nonlinear objective with ρ = 6, which we found to yield strong results that were robust to perturbations of ρ across many instances.
3. At the beginning of the time horizon, we ensure that all groups have been assigned at least one subject at random before we apply the optimization in formulation (2).
4. Toward the end of the time horizon, we set the robustness parameter Γ = 0 so as to make our algorithm more greedy and avoid overly conservative assignment decisions.
5. In all tested experiments, the CA-RO(r) algorithms for r ∈ {1, 3, 5} produced assignment recommendations instantaneously (i.e. under 1 second), which suggests that the method can be used not just for clinical trials, but also for settings requiring real-time decisions, such as experimentation for website design or marketing.
6. One can imagine a situation in which it is beneficial to exclude a given patient from the trial on the basis of extreme covariate values rather than make an assignment. While we do not consider this scenario directly in this paper, this question could be addressed through a pre-filter outlier detection process. There are modifications that could be made to the MIO formulation to allow for selective exclusion, but we leave this exploration to future work.
Empirical Performance
In this subsection, we evaluate the empirical performance of the CA-RO algorithm. First, we review four state-of-the-art CA-RAND methods, which serve as benchmarks for the CA-RO algorithm.
Second, we compare the performance of the CA-RO algorithm at various aggregation levels with pure randomization and these CA-RAND methods.
When evaluating the performance of CA-RO, we consider pure randomization (RAND) along with the matching on-the-fly algorithm of Kapelner and Krieger (2014) Atkinson (1982) (DA), and the covariate-adaptive biased coin design of Antognini and Zagoraiou (2011) (AZ). The biased coin design methodology with m = 2, generically defined as
forms the basis of the PS, DA and AZ methods, with function F (·) defined separately for each method. For the PS method, the bias φ t of the coin used in randomized allocation is defined as
where p ≥ 0.5 is the bias parameter and D(t) = 2
represents the covariate imbalance between the two groups after t−1 subjects have been assigned (with D(1) = 0). For the DA method,
for the case of one-dimensional covariates. In this definition, the value ζ represents the normalized mismatch between the two groups after t − 1 assignments. For the AZ method, we first define J + 1 discrete levels ω j of the covariate space. If subject t arrives from level ω j , then the probability of assignment of this subject into group 1 is φ t = G j (D t (ω j )), where non-increasing and symmetric functions G j are defined as follows:
and
In this description, D t (ω j ) denotes the imbalance between the two groups within the level ω j . In the KK method, subjects are either randomized to treatment groups or paired via a matching criterion based on the pairwise Mahalanobis distance. In the latter case, the new paired subject is assigned to the treatment opposite its pair in order to balance the groups. We now discuss the empirical performance of the various algorithms with respect to covariate balance. For this analysis we took data from a Mayo Clinic trial of treatment for primary biliary cirrhosis of the liver conducted between 1974 and 1984 (Therneau and Grambsch 2000) with a total of 312 patients described by 20 covariates. After running a simple logistic regression model predicting the outcome of the treatment, we identified three statistically significant covariates with the largest effect: age (C1), alkaline phosphatase in U/liter (C2), and prothrombin time in seconds (C3). We evaluated nine algorithms -RAND, PS, DA, AZ, KK and CA-RO(r) (with four different values of r) -to measure the average worst pairwise difference in generalized moments across groups with respect to three covariates described above (Table 1) . For this and all subsequent experiments when evaluating the CA-RO algorithm at any level of aggregation, we chose the robustness parameter Γ in uncertainty set (3) independently and uniformly at random from the interval [0.5, 4] at each time-step. In terms of the discrepancy in the first moment, CA-RO outperformed other CA-RAND algorithms for all standardized covariates. The discrepancy in the second moment, which closely approximates the discrepancy in the variance in this setting, was also always lower for CA-RO than for the best CA-RAND method. The discrepancy in higher moments, as well as generalized moments of log(|w|) and 1/w, for CA-RO methods was always comparable with other CA-RAND algorithms. As we expected, the advantage of optimization increases with r, and the offline OPT algorithm has significantly better performance than other approaches.
We found similar (and often stronger) results from additional experiments with synthetic data in which the covariates were generated from different types of distributions, including normal, uniform, and long-tailed Cauchy distributions. One of these experiments is discussed in Section EC.1 of the e-companion.
Statistical Power of CA-RO Algorithm
A common pre-condition for the approval of any clinical trial is to demonstrate that the trial will have a sample size sufficient to make sound statistical inferences with high probability. These inferences include both statistical power, the ability to detect a positive treatment effect when one exists, and a low type I error rate, the ability to correctly identify an ineffective treatment.
In classical statistical models, the power of a randomized controlled trial can be derived from the sample size and significance level, given an estimated treatment effect. Randomized allocation can yield an accidental imbalance in covariates between treatment groups that can impact the ability to make experimental inferences. Traditionally, when estimating treatment effects, practitioners have been satisfied to control for this covariate imbalance a posteriori via regression methods (Lin 2013).
We provide strong empirical evidence that such post hoc adjustments may produce suboptimal effect estimation, particularly when the relationship between covariates and response is nonlinear.
By testing a variety of covariate-response models, we show that, at any fixed sample size, the statistical power of a clinical trial is at least as high when covariate-adaptive optimization is used rather than covariate-adaptive randomization. In settings where the covariate-response relationship is nonlinear, we observe that the power under the CA-RO algorithm is significantly higher than for state-of-the-art CA-RAND methods. Therefore, in certain settings, the use of covariate-adaptive optimization could allow decision-makers to achieve desired levels of statistical power with significantly smaller sample size as compared with CA-RAND mechanisms. Given the high cost of enrolling human subjects in clinical trials, the ability to achieve needed statistical power with much smaller sample size can result in significant cost savings for the healthcare industry and society at large.
Test for Statistical Power
In order to compare statistical power under CA-RAND and CA-RO online allocation procedures, we apply a hypothesis testing framework based on simulation (Bertsimas et al. 2015) .
Let us assume there are m = 2 groups: a treatment group, which will be administered a given therapy, and a control group, which will be administered a placebo. There are N subjects in the trial, such that k = N/2 subjects will be assigned to each of the groups. At each time-step t = 1, . . . , N , the decision-maker observes the values of a covariate vector w t and makes a binary 15 assignment x t , where x t = 1 indicates the treatment group (1) and x t = 0 indicates the control group (0). Let v t be the response measured after the assigned treatment was administered for subject t. We adopt the potential outcomes framework of Rosenbaum and Rubin (1983) , such that each subject has a pair of potential outcomes (v
t ), where the superscript indicates treatment or control and only one of these two outcomes can be observed. Under this framework, we have the following relationship between the observed response and the potential outcomes:
Given v t for each subject t = 1, . . . , N , we can estimate the average treatment effectδ. We adopt two estimators forδ, unadjusted and regression-adjusted, from Lin (2013):
2.δ adj := β x , where β x is the estimated coefficient on x t in the ordinary least squares regression
To test the significance of this observed effectδ, we adopt Fisher's sharp null hypothesis (Fisher 1935) , which states that every subject t = 1, . . . , N would have had the same response to treatment regardless of which treatment was assigned. In other words, under the sharp null hypothesis, we
t . Equipped with a complete set of potential outcomes for each subject, we can estimate the average treatment effect under alternative random allocations of subjects 1, . . . , N .
If we compute the average treatment effect δ b as our test statistic for each alternative allocation b = 1, . . . , B, we can then estimate the p-value for our observedδ, using a two-sided test, as
We reject the null hypothesis if p ≤ α for some pre-specified significance level α; otherwise, we accept the null hypothesis.
In order to estimate the statistical power under a given algorithm A, we generate Q random samples of N subjects with covariates drawn i.i.d. from a fixed distribution. We apply the hypothesis test described above for all random samples, and measure the number of samples Q reject for which the null hypothesis is rejected. We evaluate the probability that the null hypothesis will be OPRE-2017-06-327.R2 rejected by computing the ratio λ := Q reject /Q. If the true treatment effect δ 0 is nonzero, then λ estimates the power of the experiment; otherwise, λ estimates the type I error rate.
The alternative allocations for the hypothesis test can be generated randomly using as v
Computational Results
To evaluate the statistical power of the CA-RO algorithm relative to CA-RAND methods, we simulated clinical trials under three different hidden realities, each characterized by a unique model relating treatment response to subject covariates. We assumed each subject t = 1, . . . , N had a covariate vector w t = (w 1 t , w 2 t ) of dimension S = 2, whose components were drawn i.i.d. from a standard normal distribution. The covariate-response models were as follows:
where δ 0 is the ground-truth additive treatment effect and t is a Gaussian noise term with mean 0 and standard deviation 0.75.
For each covariate-response model, we evaluated statistical power λ under the CA-RAND and CA-RO algorithms by applying the hypothesis test described in Section 4.1 with both estimatorŝ δ unadj andδ adj (Figure 1) . We considered N ∈ {40, 80, 120} with δ 0 = 0.5, Q = 800, B = 500, and significance level α = 0.05. For all scenarios, the power of the experiment increases with N . • In the NR scenario, post hoc regression adjustment does not improve power for any of the methods. All methods yield similar power since there is no benefit from covariate balance.
• Conversely, in the linear response setting (LIN), regression adjustment increases statistical power substantially for all methods. When using theδ unadj estimator, CA-RO(1) yields higher power relative to randomization and CA-RAND methods. However, post hoc regression adjustment using ordinary least squares, which exactly replicates the covariate-response model with additive treatment effect, reduces the need for the a priori covariate balance provided by CA-RO. Power evaluated usingδ adj is equally high across all methods.
• Finally, in the nonlinear response scenario described above (NL), there is virtually no benefit to using regression adjustment. In this setting, CA-RO(1) yields much higher statistical power than We conducted additional experiments under a variety of nonlinear models and found, in all tested scenarios, that CA-RO had power at least as high as (and often higher than) randomization-based methods. The NL scenario is an example in which the benefit of CA-RO was particularly dramatic.
We also ran simulations in which the p-values were estimated using a one-sided test rather than a two-sided test. As one might expect, for fixed δ 0 and distribution of noise , power was higher for all methods under the one-sided test. However, in all tested scenarios, the CA-RO algorithm maintained a similar advantage relative to other methods.
In Table 2 , we show the results for the NL setting under the CA-RO(r) assignment mechanism for N = 40 with aggregation levels r ∈ {1, 3, 5} along with OPT, which is equivalent to CA-RO(N ).
As we expect, the power increases with the aggregation level r.
In Figure 1 , we show that, under some covariate-response models, CA-RO yields higher power at fixed sample sizes than other methods. This motivates a complementary question: What is the sample size required to achieve a desired level of statistical power? We considered the NL scenario and tested values of δ 0 from 0.75 to 1.75 to estimate N * A (δ 0 ), the minimum number of subjects per group needed to achieve power of at least 80% when assignment mechanism A is employed ( Figure   2a ). With a large effect size of δ 0 = 1.75, statistical power of 80% was achieved with a sample size of 22 using the CA-RO(1) algorithm compared with a sample size of 30 using the best CA-RAND method (in this case, PS). With a small effect size of δ 0 = 0.75, the advantage of optimization was even bigger; a sample size of 58 was sufficient to achieve 80% power, compared with a sample size of 122 using the best CA-RAND method (again, PS). For a given treatment effect δ 0 , the threshold sample size needed to achieve 80% power under the CA-RO algorithm was reduced by at least 25% relative to the best CA-RAND method (Figure 2b ). If we consider the NL setting with δ 0 = 0.75
as an example, the CA-RO method may enable the execution and analysis of some clinical trials that would otherwise be infeasible given the prohibitively large sample size required to achieve a sufficient level of statistical power when CA-RAND methods are employed. We also evaluate the rate of type I errors for CA-RO(1) with δ 0 = 0 with Q = 800 and B = 500
for N ∈ {40, 80, 120} and for each of the three covariate-response scenarios described above, using the regression-adjusted treatment effect estimator (Table 4) . We observe that, for each setting, the type I error is a decreasing function of N . Type I error rates for all algorithms tested are shown in Figure EC .1 in the e-companion. PS, the CA-RAND method with the best statistical power in this experiment, had a mean type I error rate that was uniformly higher than that produced by CA-RO(1).
Unbiasedness of CA-RO Approach
In this section, we provide empirical and theoretical evidence that the CA-RO algorithm introduced in Section 3 exhibits the same statistical advantages ascribed to complete randomization by Efron (1971): freedom from selection bias, freedom from accidental bias with respect to observed and hidden covariates, and a reasoned basis for inference.
Freedom from selection bias
The CA-RO algorithm protects against selection bias, the possibility that an investigator could consciously or unconsciously influence the order of subject enrollment based on deterministic knowledge of the next treatment assignment. Through computer simulation, we demonstrate that, by selecting the robustness parameter Γ independently and uniformly at random with support [0.5, 4] at each time-step, the CA-RO method yields sufficiently random treatment assignments as to protect against this type of selection bias. For N from 30 to 100, we randomly generated 30 unique sequences of covariates w ∈ R N drawn independently from N (0, 1). We used the CA-RO(1) algorithm to generate 3,000 random assignments of the N subjects to two groups. We observe that one cannot determine the sequence of future assignments based on knowledge of the algorithm because, on average, the total number of possible allocations is large (Figure 3a ) and no individual assignment sequence has a likelihood higher than 6% (Figure 3b) .
A concern that directly competes with selection bias is certifiability. When used with a fixed and predefined sequence of robustness parameters Γ t , t = 1, . . . , N , the CA-RO algorithm is a sequence of deterministic optimization problems, each of which can be reproduced. This reproducibility provides a natural method for certifying a posteriori that the algorithm's recommendation was followed, given knowledge of the subjects' covariates and arrival order. If certifiability is deemed to be of greater concern than selection bias in the context of a particular experimental setting, one can apply the CA-RO algorithm with fixed robustness parameters in order to achieve full certifiability of assignments. Conversely, certifiability is not achievable using randomized methods unless the random seed used to initialize the algorithm is provided. Before we present Proposition 1, let us define some auxiliary notations. Sets of indices S β α , for α, β = 1, 2, describing the differences between the groups produced by algorithms A and B have the form
Freedom from accidental covariate imbalance
We also introduce the optimal objective value θ * (A) of the auxiliary pairwise matching problem:
Finally, we define the value ξ * (A, B) := min Table 3 Minimum number of subjects per group N * A (δ0) needed for power over 80%.
Treatment effect, δ 0
Algorithm, A 0.75 1 1.25 1.5 1.75 Step 1. Optimization of the linear term.
Let us define a parameterΓ := Γ 2 (N − t)S, where Γ is the robustness parameter from (3). Then, for any fixed values of p, q, s, andΓ, we consider the optimization problem
We have
where only the last term of the right-hand side depends on uncertainw. Therefore, we need to solve the following optimization problem for fixed values of components of x:
where v (s) denotes the s-th row of the matrix (Σ t )
can be rewritten in the following form:
where vector a
Application of the Karush-Kuhn-Tucker conditions yields that the optimal value of the optimization problem (EC.2) is equal to The last factor can be simplified and expressed in terms of the current time-step decision variables as follows:
where the second equality is due to the fact that x ip and x iq are binary variables with x ip x iq = 0.
Thus, the analysis of optimization problem (EC.1) allows us to write a closed-form counterpart of the linear terms in (2) that depends only on the current time-step decision variables x tp for p = 1, . . . , m, such that:
Step 2. Optimization of the variance term.
Similarly to
Step 1, we fix values of p, q, s andΓ and consider the optimization problem
As before, only the term representing the future time periods depends on the uncertain parameters ε. Therefore, the primary goal of this step is to find a closed-form solution to the auxiliary optimization problem
In (EC.4), λ max (A) denotes the maximum eigenvalue of the square block matrix A: 
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The maximum eigenvalue λ max (A) depends not only on the values of x, but also on the dimension S of the covariate space.
• Case 1. S ≥ 2. In this case, the eigenvalues of matrix B are 0 and v (s) 2 2 , and the maximum eigenvalue of matrix A can be determined as a function of x as follows:
, if x ip − x iq = 1 for at least one i = t + 1, . . . , N.
By construction, the condition x ip − x iq = 1 for at least one i = t + 1, . . . , N holds if and only if group p is not full after the current time-step assignment, i.e.,
Thus, optimization problem (EC.4) has the following closed-form solution that depends only on the current time-step decision variables:
where
(EC.5)
Now we can exploit the closed-form solution for optimization problem (EC.3) within (2), as follows: Hence, This is equivalent to the formulation:
ip − x tp = 0 and
Thus, optimization problem (2) modeling the CA-RO algorithm with ellipsoidal uncertainty set has the following closed form for S ≥ 2:
The second-to-last constraint guarantees that no group will be assigned more than k subjects and is therefore a sufficient replacement for the second-to-last constraint of formulation (2).
A similar formulation for the case S = 1 is given by
where Ψ p (x, x) and Ψ q (x, x) are as defined in (EC.5); Θ pq (x, x) and Θ qp (x, x) are as defined in (EC.6).
Corollary 1. To find the optimal objective value of discrete optimization problem (EC.7) and (EC.8) and the optimal current assignment at time t, it is sufficient to inspect the following easily specified set X consisting of not more than m points:
x tp = 1;
x tq = 0, ∀q = 1, . . . , m, q = p;
x iu = 0, ∀i = t + 1, . . . , N, u = 1, . . . , m;
Proof. Formulations (EC.7) and (EC.8) depend only on current time-step decisions x tp , for p = 1, . . . , m. Given that these variables are binary and the subject with index t must be assigned to exactly one group, it is sufficient to inspect the set X , with cardinality at most m, to solve (2) for the optimal current assignment.
EC.3. CARO algorithm with patient exclusion
In this section, we consider an extended clinical trial setting that allows a decision-maker to exclude some patients from a trial due to their extreme covariate values that may aggravate final betweengroup balance.
Following the notation from Section 3, we assume that in the new setting the total number of subjects in a trial is N + N 0 , where N 0 is the maximum number of subjects to be excluded, as In this formulation, the last two constraints state that each subject should be either excluded from the trial or assigned to one of the m groups; and the total number of excluded subjects cannot exceed the upper bound N 0 . The definition of uncertainty set U w takes into account an increased ec10 e-companion to Bertsimas, Korolko and Weinstein: Covariate-Adaptive Optimization in Online Clinical Trials
The next step is to express the between-group discrepancies in the means generated by algorithms A and B as follows: This proposition has a straighforward extension to the cases of m > 2 groups and multidimensional covariates. The proofs have a similar structure to the case considered here, and thus are omitted. 
